Immunotherapy and Radioimmunotherapy for Desmoplastic Small Round Cell Tumor

por Espinosa-Cotton, Madelyn, Cheung, Nai-Kong V.
Publicado 2021

Identification of immunotherapy and radioimmunotherapy targets on desmoplastic small round cell tumors

por Espinosa-Cotton, Madelyn, Guo, Hong-Fen, Tickoo, Satish K., Cheung, Nai-Kong V.
Publicado 2023

Overcoming leukemia heterogeneity by combining T cell engaging bispecific antibodies

por Hoseini, Sayed Shahabuddin, Espinosa-Cotton, Madelyn, Guo, Hong-fen, Cheung, Nai-Kong V
Publicado 2020

Targeting tumor vasculature to improve antitumor activity of T cells armed ex vivo with T cell engaging bispecific antibody

por Park, Jeong A, Espinosa-Cotton, Madelyn, Guo, Hong-fen, Monette, Sebastien, Cheung, Nai-Kong V
Publicado 2023

Desmoplastic small round cell tumor cancer stem cell-like cells resist chemotherapy but remain dependent on the EWSR1-WT1 oncoprotein

por Magrath, Justin W., Kang, Hong-Jun, Hartono, Alifiani, Espinosa-Cotton, Madelyn, Somwar, Romel, Ladanyi, Marc, Cheung, Nai-Kong V., Lee, Sean B.
Publicado 2022

T cell engaging bispecific antibodies targeting CD33 IgV and IgC domains for the treatment of acute myeloid leukemia

por Hoseini, Sayed Shahabuddin, Vadlamudi, Mallika, Espinosa-Cotton, Madelyn, Tran, Hoa, Feng, Yi, Guo, Hong-fen, Xu, Hong, Cheung, Irene, Cheung, Nai-Kong V
Publicado 2021

Genomic Breakpoint Characterization and Transcriptome Analysis of Metastatic, Recurrent Desmoplastic Small Round Cell Tumor

por Magrath, Justin W., Flinchum, Dane A., Hartono, Alifiani B., Goldberg, Ilon N., Espinosa-Cotton, Madelyn, Moroz, Krzysztof, Cheung, Nai-Kong V., Lee, Sean B.
Publicado 2023

Impact of Nuclear Interleukin-1 Alpha and EGFR Expression on Recurrence and Survival Outcomes in Oral Squamous Cell Carcinomas

por Rajan, Anand, Gibson-Corley, Katherine N., Choi, Allen B., Ofori-Amanfo, Georgina K., Ten Eyck, Patrick, Espinosa-Cotton, Madelyn, Sperry, Steven M., Simons, Andrean L.
Publicado 2019

A preliminary analysis of interleukin-1 ligands as potential predictive biomarkers of response to cetuximab

por Espinosa-Cotton, Madelyn, Fertig, Elana J., Stabile, Laura P., Gaither-Davis, Autumn, Bauman, Julie E., Schmitz, Sandra, Gibson-Corley, Katherine N., Cheng, Yinwen, Jensen, Isaac J., Badovinac, Vladimir P., Laux, Douglas, Simons, Andrean L.
Publicado 2019

Interleukin-1 alpha increases anti-tumor efficacy of cetuximab in head and neck squamous cell carcinoma

por Espinosa-Cotton, Madelyn, Rodman III, Samuel N., Ross, Kathleen A., Jensen, Isaac J., Sangodeyi-Miller, Kenley, McLaren, Ayana J., Dahl, Rachel A., Gibson-Corley, Katherine N., Koch, Adam T., Fu, Yang-Xin, Badovinac, Vladimir P., Laux, Douglas, Narasimhan, Balaji, Simons, Andrean L.
Publicado 2019

Zenocutuzumab, a HER2xHER3 Bispecific Antibody, Is Effective Therapy for Tumors Driven by NRG1 Gene Rearrangements

por Schram, Alison M., Odintsov, Igor, Espinosa-Cotton, Madelyn, Khodos, Inna, Sisso, Whitney J., Mattar, Marissa S., Lui, Allan J.W., Vojnic, Morana, Shameem, Sara H., Chauhan, Thrusha, Torrisi, Jean, Ford, Jim, O'Connor, Marie N., Geuijen, Cecile A.W., Schackmann, Ron C.J., Lammerts van Bueren, Jeroen J., Wasserman, Ernesto, de Stanchina, Elisa, O'Reilly, Eileen M., Ladanyi, Marc, Drilon, Alexander, Somwar, Romel
Publicado 2022